Trial Profile

Randomized, Parallel, Placebo-controlled study, to assess the safety, tolerability, and efficacy of PH Gastrilex (Amorphous calcium carbonate (ACC)) in the treatment of adult subjects with moderate to severe Crohn's Disease (Israeli Ministry of health study number: MOH_2023-05-01_012591).

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 26 Feb 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 Feb 2026 According to Amorphical Media Release, data from the trial will be presented at the European Crohn's and Colitis Organisation (ECCO) Congress in Berlin.
17 Feb 2026 Results presented in the Amorphical Media Release
16 Dec 2025 Results presented in the Amorphical Media Release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com